Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
GLOBUS MEDICAL INC
Bear Case (25th pct.)
-26.1% vs price
Base Case (Median)
-9.6% vs price
Bull Case (75th pct.)
33.8% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $57.35 | -24.1% | High (40%) |
| PE Comparable | $87.35 | 15.5% | Medium (25%) |
| Growth Trajectory DCF | $148.95 | 97.0% | Medium (20%) |
| Graham Number | $54.44 | -28.0% | Medium (40%) |
| EV/EBITDA | $68.31 | -9.6% | Medium (20%) |
| EV/FCF | $114.91 | 52.0% | Medium (20%) |
| Earnings Power Value | $20.20 | -73.3% | Medium (50%) |
Based on 7 out of 7 methods, GMED appears fairly valued at the current price of $75.60. The base case fair value of $68.31 implies 9.6% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.